More about

Treprostinil

News
January 18, 2022
2 min read
Save

Pulmonary hypertension year in review: Inhaled therapy, improving mortality trends in US

Pulmonary hypertension year in review: Inhaled therapy, improving mortality trends in US

The Healio Editors compiled the most-read pulmonary hypertension news published in 2021.

News
November 30, 2021
4 min read
Save

Treatment options expanding for progressive fibrosing ILD

Treatment options expanding for progressive fibrosing ILD

A speaker at the PFF Summit highlighted recent trials and therapeutic updates for progressive fibrosing interstitial lung disease.

News
June 02, 2021
2 min read
Save

Differences in hospitalization-related costs with oral PAH therapies

Differences in hospitalization-related costs with oral PAH therapies

Treatment with selexipag could save payers costs over 2 years compared with oral treprostinil, according to results of a comparative cost model reported at the Academy of Managed Care Pharmacy virtual meeting.

News
May 18, 2021
2 min read
Save

Multiple disease progression events less likely with continued inhaled treprostinil

Multiple disease progression events less likely with continued inhaled treprostinil

In a post hoc analysis of the INCREASE study, patients with interstitial lung disease-associated pulmonary hypertension who continued inhaled treprostinil were less likely to experience further disease progression events vs. placebo.

News
May 10, 2021
5 min read
Save

Risk stratification, improved therapies important in PAH

Risk stratification, improved therapies important in PAH

For physicians, pulmonary artery hypertension poses many challenges, including the need for greater awareness and better therapies, according to an expert who spoke with Healio.

News
May 05, 2021
2 min read
Save

Recent pulmonary hypertension updates: New therapies, women’s health and more

Recent pulmonary hypertension updates: New therapies, women’s health and more

The Healio Editors have compiled a list of recent articles about pulmonary hypertension in recognition of World Pulmonary Hypertension Day.

News
April 05, 2021
2 min read
Save

FDA approves inhaled treprostinil for pulmonary hypertension associated with ILD

FDA approves inhaled treprostinil for pulmonary hypertension associated with ILD

The FDA approved inhaled treprostinil for the treatment of patients with pulmonary hypertension associated with interstitial lung disease, according to a press release from United Therapeutics.

News
January 15, 2021
2 min read
Save

Updates in pulmonary hypertension treatments, FDA approvals and more from 2020

Updates in pulmonary hypertension treatments, FDA approvals and more from 2020

The Healio editors have compiled a list of the most-read pulmonary arterial hypertension news published in 2020.

News
August 19, 2020
2 min read
Save

Recent updates in pulmonary hypertension: New treatment options, inhaled therapy and more

Recent updates in pulmonary hypertension: New treatment options, inhaled therapy and more

The Healio editors have compiled a list of recent updates in the management and treatment of pulmonary hypertension.

News
August 06, 2020
2 min read
Save

Inhaled treprostinil improves QOL, other exploratory outcomes in patients with PAH

Inhaled treprostinil improves QOL, other exploratory outcomes in patients with PAH

New exploratory endpoint data from the INSPIRE study show improvements after 2 months of treatment with inhaled treprostinil in quality of life, 6-minute walk distance and New York Heart Association functional class.

View more